THE LATEST

Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims

By Grabar Law | Apr 19, 2025

A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...

Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors

By Grabar Law | Apr 19, 2025

Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...

Grabar Law Office In The News: Block’s Dorsey, Others Face Derivative Suit Over AML Woes

By Grabar Law | Feb 9, 2025

Officers and directors of Square and Cash App parent company Block Inc. face a shareholder derivative complaint over alleged anti-money ...

Grabar Law Office In The News: Micron CEO Accused Of Insider Trading In Fla. Investor Suit

By Grabar Law | Jan 24, 2025

A Micron Technology Inc. shareholder has accused the company CEO and several board members of insider trading after selling $70 million worth ...

GRABAR LAW OFFICE IN THE NEWS: Biotech Co.’s Facility Failures Lost Investors Money, Suit Says

By Grabar Law | Jan 10, 2025

The executives and directors of biotechnology company Humacyte Inc. have been hit with a shareholder derivative suit in North Carolina ...

GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF MERCHANTS THAT ACCEPT VISA DEBIT CARDS

By Grabar Law | Nov 3, 2024

Grabar Law Office has filed a significant class action lawsuit against Visa Inc., alleging that Visa has systematically abused its ...

GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF INDEPENDENT PHARMACIES AGAINST GOODRX AND MAJOR PBMS

By Grabar Law | Nov 3, 2024

Grabar Law Office has filed a class action lawsuit on behalf of independent pharmacies, challenging the anticompetitive practices of GoodRx ...

Grabar Law Office In the News: Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection

By Grabar Law | Oct 23, 2024

Current and former officers and directors of dermatological medication maker Verrica Pharmaceuticals Inc. face a shareholder derivative action alleging the ...

Grabar Law Office In the News: Biotech Execs Face Investor Suit Over Medicare Claims

By Grabar Law | Sep 11, 2024

Executives and directors of biopharmaceutical company Ardelyx have been hit with a shareholder derivative suit in Massachusetts federal court alleging ...

Grabar Law Office In The News: UnitedHealth Brass Face Investor Suit Over Merger Probe

By Grabar Law | Jul 9, 2024

Executives and directors of UnitedHealth Group were hit with a shareholder derivative suit alleging they concealed that the U.S. Department ...

Grabar Law Office Files Federal Class Action on Behalf of Purchasers of the Common Stock of iAnthus Capital Holdings, Inc.

By Grabar Law | Apr 15, 2020

Grabar Law Office has filed a federal class action on behalf of purchasers of the common stock of iAnthus Capital ...

Grabar Law Office Files Class Action Against Robinhood Financial LLC On Behalf Of Investors Damaged By The Outage Of Robinhood’s Trading Platform

By Grabar Law | Apr 7, 2020

As alleged in the Complaint, Robinhood’s trading systems completely crashed on Monday, March 2, 2020, and experienced a total outage ...

Grabar Law Office Files Securities Class Action On Behalf of Shareholders of Sterling Bancorp

By Grabar Law | Mar 27, 2020

Grabar Law Office has filed a federal class action brought individually and on behalf of all other persons and entities ...

Caustic Soda Manufacturers Lose Bid to Dismiss Price-Fixing Class Action

By Grabar Law | Mar 27, 2020

A group of chemical companies including Occidental Chemical and Olin lost motions to dismiss litigation accusing them of fixing prices ...

Grabar Law Office Files Class Action on Behalf of Purchasers of the Common Ctock of Cronos Under the Securities Exchange Act of 1934

By Grabar Law | Mar 12, 2020

Grabar Law Office has filed a federal class action on behalf of purchasers (the “Class”) of the common stock of Cronos, ...

Defendants Can’t Escape Polyurethane Price-Fixing MDL

By Grabar Law | Mar 10, 2020

Per the Opinion denying Defendants' motion to dismiss in In Re: Diisocyanates Antitrust Litigation, 2:18-mc-01001 (W.D. Pa.), the court determined that ...